Evidence map›Paper›PMID 37208224›Full record

ArticleTransplantation proceedings2023

A Case of Acute Kidney Injury Caused by Myoglobin Cast Nephropathy With Sars-Cov-2 Infection in a Living-Donor Kidney Transplant Recipient.

Daihi Sato, Shinichiro Tsunoda, Tomoko Namba-Hamano, Masahiro Kyo, Kumi Kusumi, Atsuyuki Morishima, Katsuhiko Sakaguchi, Yuki Matsunaga, Shigeki Fujita, Yutaka Yamaguchi

Open access · greenAbstract readCase Reports
In one paragraph

Article in Transplantation proceedings, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Daihi SatoDepartment of Kidney Center, Sumitomo Hospital, Osaka, Japan. Electronic address: c201101023@gmail.com.
Shinichiro TsunodaDepartment of Kidney Center, Sumitomo Hospital, Osaka, Japan.
Tomoko Namba-HamanoDepartment of Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan.
Masahiro KyoSeiwa Hospital, Osaka, Japan.
Kumi KusumiDepartment of Kidney Center, Sumitomo Hospital, Osaka, Japan.
Atsuyuki MorishimaDepartment of Kidney Center, Sumitomo Hospital, Osaka, Japan.
Katsuhiko SakaguchiDepartment of Kidney Center, Sumitomo Hospital, Osaka, Japan.
Yuki MatsunagaDepartment of Pathology, Sumitomo Hospital, Osaka, Japan.
Shigeki FujitaDepartment of Pathology, Sumitomo Hospital, Osaka, Japan.
Yutaka YamaguchiYamaguchi's Pathology Laboratory, Chiba, Japan.
Sumitomo Hospital · JPSeiwa Hospital · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When COVID-19 affects patients with risk factors such as chronic kidney disease or on immunosuppressive drugs, they often rapidly become seriously ill. We describe a 50-year-old man who was affected with SARS-CoV-2 and had undergone an ABO-compatible living-donor kidney transplantation from his father 14 years ago because of end-stage renal failure due to hypertensive nephrosclerosis. He had continued on immunosuppressive drugs and completed vaccination twice (9 months ago and 6 months ago) with messenger RNA (mRNA) vaccines against SARS-CoV-2. However, he was temporarily on a mechanical ventilator due to respiratory failure and hemodialysis due to acute kidney injury (AKI). He was finally weaned from the ventilator and hemodialysis by taking steroid and antiviral drugs. Echo-guided renal biopsy revealed myoglobin cast nephropathy. We experienced 14 outpatients after living-donor kidney transplantation infected with SARS-CoV-2, but only this case developed AKI.

Indexed as

Acute Kidney InjuryCOVID-19Kidney TransplantationCOVID-19 VaccinesHumansImmunosuppressive AgentsLiving DonorsMaleMiddle AgedMyoglobinSARS-CoV-2COVID-19 VaccinesImmunosuppressive AgentsMyoglobin

Identifiers

PMID37208224
PMCPMC10076507
OpenAlexW4362669940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.